Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-023716
Filing Date
2025-08-14
Accepted
2025-08-14 07:31:16
Documents
83
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1272777
2 EX-10.1 ex10-1.htm EX-10.1 205461
3 EX-31.1 ex31-1.htm EX-31.1 15608
4 EX-31.2 ex31-2.htm EX-31.2 15526
5 EX-32 ex32.htm EX-32 12758
  Complete submission text file 0001641172-25-023716.txt   7507283

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abeo-20250630.xsd EX-101.SCH 48901
7 XBRL CALCULATION FILE abeo-20250630_cal.xml EX-101.CAL 72430
8 XBRL DEFINITION FILE abeo-20250630_def.xml EX-101.DEF 211154
9 XBRL LABEL FILE abeo-20250630_lab.xml EX-101.LAB 469752
10 XBRL PRESENTATION FILE abeo-20250630_pre.xml EX-101.PRE 380487
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1206407
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 251214358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)